Testing effectiveness (Phase 2)Study completedNCT00946270What this trial is testingPomalidomide for Myelofibrosis PatientsWho this might be right forPolycythemia VeraThrombocythemia M.D. Anderson Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT01259856What this trial is testingRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Who this might be right forHigh Risk Polycythemia VeraHigh Risk Essential Thrombocythemia Ronald Hoffman 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262141What this trial is testingIMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)Who this might be right forEssential ThrombocythemiaPolycythemia Vera Terrence J Bradley, MD 4
Testing effectiveness (Phase 2)Study completedNCT00509899What this trial is testingOpen Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisWho this might be right forMyelofibrosisPolycythemia VeraThrombocytosis Incyte Corporation 154
Large-scale testing (Phase 3)Study completedNCT03952039What this trial is testingAn Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With RuxolitinibWho this might be right forPrimary MyelofibrosisPost-Polycythemia VeraMyelofibrosis Celgene 202
Not applicableStudy completedNCT03625895What this trial is testingAgrylin Drug Use-Result SurveyWho this might be right forEssential Thrombocythemia (ET) Takeda 1,826
Large-scale testing (Phase 3)Active Not RecruitingNCT04285086What this trial is testingRopeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntoleranceWho this might be right forEssential Thrombocythemia PharmaEssentia 174
Early research (Phase 1)Active Not RecruitingNCT04041050What this trial is testingA Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmWho this might be right forMyeloproliferative Neoplasm AbbVie 85
Testing effectiveness (Phase 2)Looking for participantsNCT06327100What this trial is testingOpen Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)Who this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-Essential Thrombocytosis Myelofibrosis M.D. Anderson Cancer Center 33
Not applicableLooking for participantsNCT06734637What this trial is testingEfficacy and Safety of Peginterferon in ET and PV.Who this might be right forEssential ThrombocythemiaPolycythemia Vera Zhenya Hong 40
Testing effectiveness (Phase 2)UnknownNCT01298934What this trial is testingLBH589 (Panobinostat) for the Treatment of MyelofibrosisWho this might be right forPrimary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis Ronald Hoffman 22
Testing effectiveness (Phase 2)Ended earlyNCT00630994What this trial is testingLow-Dose Decitabine in Treating Patients With Symptomatic MyelofibrosisWho this might be right forChronic Myeloproliferative DisordersSecondary Myelofibrosis Mayo Clinic 4
Early research (Phase 1)Looking for participantsNCT05025488What this trial is testingMutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative NeoplasmWho this might be right forMyelofibrosisEssential ThrombocythemiaMPN Marina Kremyanskaya 10
Testing effectiveness (Phase 2)Study completedNCT01259817What this trial is testingPegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)Who this might be right forHigh Risk Polycythemia VeraHigh Risk Essential Thrombocythemia Ronald Hoffman 135
Not applicableStudy completedNCT01816256What this trial is testingScreening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsWho this might be right forMyeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)+1 more University Health Network, Toronto 102
Testing effectiveness (Phase 2)Ended earlyNCT02730884What this trial is testingSingle-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and AnemiaWho this might be right forLeukemiaMyelofibrosisAnemia+1 more M.D. Anderson Cancer Center 3
Early research (Phase 1)Ended earlyNCT01291784What this trial is testingAnti-TGF-beta Therapy in Patients With MyelofibrosisWho this might be right forMyelofibrosisPrimary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more John Mascarenhas 3
Not applicableStudy completedNCT00715247What this trial is testingPolycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET GenesWho this might be right forPolycythemia VeraEssential ThrombocythemiaMyelofibrosis University of Utah 726
Early research (Phase 1)Ended earlyNCT04637009What this trial is testingTAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm Astex Pharmaceuticals, Inc. 20
Large-scale testing (Phase 3)Study completedNCT02101268What this trial is testingEfficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MFWho this might be right forPrimary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Sierra Oncology LLC - a GSK company 156